HIV感染状态与胎盘蜕膜动脉病及VEGF-A表达的关系
该研究对具有至少一项母体血管灌注不良(MVM)危险因素的胎盘进行大体、组织学及VEGF-A免疫组化检测,比较HIV阳性与阴性孕妇的胎盘病理特征。结果显示VEGF-A在蜕膜和绒毛内皮中普遍表达,且表达模式不因母体HIV血清状态而异;MVM在因VEGF-A染色而选中的胎盘中更常见(51% vs 8%,P < .001)。
要点
- 在具有MVM危险因素的孕妇中,胎盘VEGF-A免疫染色普遍存在。
- VEGF-A在蜕膜和绒毛内皮中的表达模式不因母体HIV血清状态而不同。
- 因VEGF-A染色选中的胎盘MVM发生率显著高于未选中者(51% vs 8%)。
核心结论
- 在具有MVM危险因素的孕妇中,胎盘VEGF-A免疫染色普遍存在,且染色模式不因母体HIV血清状态而异,提示VEGF-A在胎盘血管病中的作用可能不因HIV感染状态而不同。
研究设计与样本
- 对具有至少一项MVM危险因素的胎盘进行大体、组织学检查及VEGF-A免疫组化染色,并按母体HIV血清状态比较病理特征。
- VEGF-A染色评估的41例胎盘中27例(66%)来自HIV感染女性;母体平均年龄27岁。
- HIV感染女性中位CD4 T细胞计数440/µL,74%HIV病毒载量检测不到。
主要发现
- VEGF-A染色的胎盘中,蜕膜和绒毛内皮组织层同时存在者36例(88%)。
- 蜕膜存在者中VEGF-A检出31/36(86%),绒毛内皮存在者中检出39/40(98%)。
- 任何组织类型中VEGF-A存在与否均不因母体HIV血清状态而异(P = .28至>.99)。
- 因VEGF-A染色选中的胎盘MVM更常见(51% vs 8%;P < .001)。
临床怎么用
- 对于具有MVM危险因素的HIV感染孕妇,胎盘VEGF-A表达模式与未感染孕妇相似,提示VEGF-A相关胎盘血管病机制可能不因HIV状态而不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women with human immunodeficiency virus (HIV) (WHIV) are at higher risk of adverse birth outcomes. Proposed mechanisms for the increased risk include placental arteriopathy (vasculopathy) and maternal vascular malperfusion (MVM) due to antiretroviral therapy and medical comorbid conditions. However, these features and their underlying pathophysiologic mechanisms have not been well characterized in WHIV. METHODS: We performed gross and histologic examination and immunohistochemistry staining for vascular endothelial growth factor A (VEGF-A), a key angiogenic factor, on placentas from women with ≥1 MVM risk factors including: weight below the fifth percentile, histologic infarct or distal villous hypoplasia, nevirapine-based antiretroviral therapy, hypertension, and preeclampsia/eclampsia during pregnancy. We compared pathologic characteristics by maternal HIV serostatus. RESULTS: Twenty-seven of 41 (placentas 66%) assessed for VEGF-A were from WHIV. Mean maternal age was 27 years. Among WHIV, median CD4 T-cell count was 440/µL, and the HIV viral load was undetectable in 74%. Of VEGF-A-stained placentas, both decidua and villous endothelium tissue layers were present in 36 (88%). VEGF-A was detected in 31 of 36 (86%) with decidua present, and 39 of 40 (98%) with villous endothelium present. There were no differences in VEGF-A presence in any tissue type by maternal HIV serostatus (P = .28 to >.99). MVM was more common in placentas selected for VEGF-A staining (51 vs 8%; P < .001). CONCLUSIONS: VEGF-A immunostaining was highly prevalent, and staining patterns did not differ by maternal HIV serostatus among those with MVM risk factors, indicating that the role of VEGF-A in placental vasculopathy may not differ by maternal HIV serostatus.
引用
- Bebell LM, Parks K, Le MH, et al. Placental Decidual Arteriopathy and Vascular Endothelial Growth Factor A Expression Among Women With or Without Human Immunodeficiency Virus. J Infect Dis. 2021. PMID: 33880547. doi:10.1093/infdis/jiab201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。